Edition:
United Kingdom

Clariant AG (CLN.S)

CLN.S on Virt-X Level 1

27.45CHF
15 Dec 2017
Change (% chg)

CHF0.15 (+0.55%)
Prev Close
CHF27.30
Open
CHF27.30
Day's High
CHF27.45
Day's Low
CHF27.09
Volume
5,960,077
Avg. Vol
3,005,061
52-wk High
CHF27.45
52-wk Low
CHF16.82

Select another date:

Mon, Dec 4 2017

Photo

Clariant open to M&A deals as it deals with activist: CEO

ZURICH Swiss specialty chemicals group Clariant is open to making fresh acquisitions as it deals with activist investor White Tale, its biggest shareholder, Chief Executive Hariolf Kottmann said in an interview with a local broadcaster on Monday.

Clariant open to M&A deals as it deals with activist -CEO

ZURICH, Dec 4 Swiss speciality chemicals group Clariant is open to making fresh acquisitions as it deals with activist investor White Tale, its biggest shareholder, Chief Executive Hariolf Kottmann said in an interview with a local broadcaster on Monday.

Activist White Tale to take demands to Clariant shareholders

ZURICH Activist investor White Tale said it would take its demands directly to Clariant's shareholders after the chemicals maker snubbed its request for an independent strategic review and three seats on its board of directors.

UPDATE 2-Activist White Tale to take demands to Clariant shareholders

ZURICH, Nov 28 Activist investor White Tale said it would take its demands directly to Clariant's shareholders after the chemicals maker snubbed its request for an independent strategic review and three seats on its board of directors.

Activist White Tale to take demands to Clariant shareholders

ZURICH Activist investor White Tale said it would take its demands directly to Clariant's shareholders after the Swiss speciality chemicals maker snubbed its request for an independent strategic review and three seats on its board of directors.

Swiss stocks - Factors to watch on Nov 28

ZURICH, Nov 28 Here are some of the main factors that may affect Swiss stocks on Tuesday:

BRIEF-‍White Tale responds on Clariant statement​

* WHITE TALE HOLDINGS - ‍DISAPPOINTED BY RECENT STATEMENT OF BOARD OF CLARIANT ON NOVEMBER 24, 2017​

Breakingviews - Clariant and activist lack a positive reaction

LONDON (Reuters Breakingviews) - It’s easier for an activist to oppose than propose. That’s the straightforward lesson from Clariant’s struggle with its largest investor, White Tale. The 20 percent shareholder scuppered the Swiss chemicals maker’s merger with U.S. rival Huntsman. Determining what happens next, however, will require powers of persuasion.

Clariant snubs review demand as showdown with White Tale looms

ZURICH Clariant on Friday rejected its largest shareholder White Tale's demand for an independent strategic review and three board seats, setting up a showdown with the activist investor which blocked its $20 billion merger with Huntsman .

Clariant snubs review demand as showdown with White Tale looms

ZURICH Clariant on Friday rejected its largest shareholder White Tale's demand for an independent strategic review and three board seats, setting up a showdown with the activist investor which blocked its $20 billion merger (£15.03 billion) with Huntsman .

Select another date: